FINWIRES · TerminalLIVE
FINWIRES

Gilead's Yeztugo Launch Shows Mix of Perspectives, RBC Says

By

-- Gilead Sciences' (GILD) Yeztugo launch is off to a solid start, though not tracking towards a transformational prospect, RBC Capital Markets said in a Friday note.

Yeztugo is a prescription medicine used as HIV-1 pre-exposure prophylaxis to reduce the risk of getting HIV-1.

The report said feedback from a mini symposium, key opinion leaders and a payer showed a largely positive experience and improving access while noting challenges in catalyzing overall pre-exposure prophylaxis growth, and early bolus could slow.

"Overall, Yeztugo launch feels solid early, akin to a better Apretude...but not necessarily the mass-market transformational prophylactic we believe was initially hoped for," the report said.

The note added that this is likely reflected in consensus' $7 billion peak sales estimate and in its shares.

RBC kept its sector perform rating with a price target of $123.

Price: $137.88, Change: $-0.67, Percent Change: -0.48%

Related Articles

Mining & Metals

ACT Energy Technologies Repays US$20.0 Million of Exchangeable Subordinated Promissory Note

ACT Energy Technologies (ACX.TO) repaid in full the outstanding exchangeable subordinated promissory note, issued in connection with its acquisition of Rime Downhole Technologies, on July 11, 2023, it said on Monday.The company repaid US$20.0 million of the note, plus accrued interest. The early repayment of the note was funded using the available US$20.0 million term facility provided by the company's syndicate of lenders, it said.Shares of the company closed up 4.1% to $6.68 on Friday on the Toronto Stock Exchange.

$ACX.TO
Treasury

Canada to Announce Creation of A Sovereign Wealth Fund This Morning, says Scotiabank

The Canadian federal government, led by Prime Minister Mark Carney, will announce a new sovereign wealth fund in a press conference at 9:15 a.m. ET on Monday in Ottawa, while Finance Minister Francois-Philippe Champagne will follow that up with a press conference at 10 a.m. ET in Montreal, says Scotiabank in its Monday morning note.The announcements around the fund will come ahead of Tuesday's Spring economic update from the federal government and, further down the road, ahead of a September investment conference that the Carney administration is planning, aimed at attracting global investment to Canada, notes Scotiabank."The devil will be very much in the details", says the bank of the new fund.One immediate observation from Scotiabank is that usually countries with sovereign wealth funds are net savers. Canada isn't.

$$CXY
Equities

Jefferies Adjusts Price Target on EQT to $77 From $76, Maintains Buy Rating

EQT (EQT) has an average rating of overweight and mean price target of $70.76, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$EQT